Creo Medical Group PLC (AIM:CREO) reported back on what it described as a hugely successful Digestive Disease Week - which is the world's premier meeting for physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
"It's fantastic to see the significant increase in sales leads, orders and broader interest from every corner of the globe during and following what has been a hugely productive DDW for Creo,” said David Woods, Creo chief commercial officer.